RU2017127182A - Анализ для детекции dpp-4 человека - Google Patents
Анализ для детекции dpp-4 человека Download PDFInfo
- Publication number
- RU2017127182A RU2017127182A RU2017127182A RU2017127182A RU2017127182A RU 2017127182 A RU2017127182 A RU 2017127182A RU 2017127182 A RU2017127182 A RU 2017127182A RU 2017127182 A RU2017127182 A RU 2017127182A RU 2017127182 A RU2017127182 A RU 2017127182A
- Authority
- RU
- Russia
- Prior art keywords
- antibody
- derivative
- variant
- produced
- fragment
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title claims 36
- 239000012634 fragment Substances 0.000 claims 114
- 210000004408 hybridoma Anatomy 0.000 claims 92
- 239000000427 antigen Substances 0.000 claims 72
- 102000036639 antigens Human genes 0.000 claims 72
- 108091007433 antigens Proteins 0.000 claims 72
- 229940126619 mouse monoclonal antibody Drugs 0.000 claims 35
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 claims 27
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims 27
- 238000000034 method Methods 0.000 claims 17
- 238000004113 cell culture Methods 0.000 claims 12
- 239000000523 sample Substances 0.000 claims 11
- 238000003018 immunoassay Methods 0.000 claims 10
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 8
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 8
- 208000006673 asthma Diseases 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 239000013598 vector Substances 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 239000007787 solid Substances 0.000 claims 5
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims 4
- 229960002685 biotin Drugs 0.000 claims 4
- 235000020958 biotin Nutrition 0.000 claims 4
- 239000011616 biotin Substances 0.000 claims 4
- 239000013522 chelant Substances 0.000 claims 4
- 239000003246 corticosteroid Substances 0.000 claims 4
- 229960001334 corticosteroids Drugs 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 229910052707 ruthenium Inorganic materials 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 206010012442 Dermatitis contact Diseases 0.000 claims 2
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 210000000628 antibody-producing cell Anatomy 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 208000010247 contact dermatitis Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- 235000011330 Armoracia rusticana Nutrition 0.000 claims 1
- 240000003291 Armoracia rusticana Species 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims 1
- 208000000592 Nasal Polyps Diseases 0.000 claims 1
- 102000003992 Peroxidases Human genes 0.000 claims 1
- 206010036790 Productive cough Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010050207 Skin fibrosis Diseases 0.000 claims 1
- 108010090804 Streptavidin Proteins 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 208000023819 chronic asthma Diseases 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 claims 1
- 239000013068 control sample Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 210000002919 epithelial cell Anatomy 0.000 claims 1
- 208000024711 extrinsic asthma Diseases 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 239000013610 patient sample Substances 0.000 claims 1
- 108040007629 peroxidase activity proteins Proteins 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 230000000391 smoking effect Effects 0.000 claims 1
- 210000003802 sputum Anatomy 0.000 claims 1
- 208000024794 sputum Diseases 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562101697P | 2015-01-09 | 2015-01-09 | |
| US62/101,697 | 2015-01-09 | ||
| PCT/US2016/012603 WO2016112261A2 (en) | 2015-01-09 | 2016-01-08 | Assay to detect human dpp-4 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2017127182A true RU2017127182A (ru) | 2019-02-11 |
Family
ID=56356576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017127182A RU2017127182A (ru) | 2015-01-09 | 2016-01-08 | Анализ для детекции dpp-4 человека |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10351630B2 (enExample) |
| EP (1) | EP3242686B1 (enExample) |
| JP (1) | JP2018502577A (enExample) |
| KR (1) | KR20170098941A (enExample) |
| CN (1) | CN107206079A (enExample) |
| AU (1) | AU2016205188A1 (enExample) |
| BR (1) | BR112017011724A2 (enExample) |
| CA (1) | CA2970540A1 (enExample) |
| HK (2) | HK1243953A1 (enExample) |
| IL (1) | IL252528A0 (enExample) |
| MX (1) | MX2017008748A (enExample) |
| RU (1) | RU2017127182A (enExample) |
| SG (1) | SG11201705598VA (enExample) |
| WO (1) | WO2016112261A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118359716A (zh) * | 2023-01-18 | 2024-07-19 | 江苏众红生物工程创药研究院有限公司 | 抗cd26抗体及其用途 |
| CN118791612A (zh) * | 2023-04-14 | 2024-10-18 | 江苏众红生物工程创药研究院有限公司 | 靶向cd26的抗原结合蛋白及其药物应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681718A (en) | 1986-03-14 | 1997-10-28 | Celltech Limited | Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof |
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| US7115555B2 (en) * | 1998-07-09 | 2006-10-03 | Baylor College Of Medicine | Hypohidrotic ectodermal dysplasia genes and proteins |
| US6573096B1 (en) * | 2000-04-01 | 2003-06-03 | The Research Foundation At State University Of New York | Compositions and methods for inhibition of cancer invasion and angiogenesis |
| CA2446806A1 (en) * | 2001-05-11 | 2002-11-21 | Board Of Regents, The University Of Texas System | Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
| GB0216648D0 (en) | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
| EP1631680A2 (en) | 2003-05-21 | 2006-03-08 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| WO2005075514A2 (en) | 2004-03-10 | 2005-08-18 | Lonza Ltd. | Method for producing antibodies |
| US7462698B2 (en) * | 2005-07-22 | 2008-12-09 | Y's Therapeutics Co., Ltd. | Anti-CD26 antibodies and methods of use thereof |
| WO2008091814A2 (en) | 2007-01-22 | 2008-07-31 | Wyeth | Assessment of asthma and allergen-dependent gene expression |
| RU2607569C2 (ru) | 2008-03-31 | 2017-01-10 | Дженентек, Инк. | Композиции и способы для лечения и диагностики астмы |
| US20100221752A2 (en) | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
| WO2012031122A2 (en) * | 2010-09-03 | 2012-03-08 | Immport Therapeutics, Inc. | Methods and compositions for the diagnosis and treatment of cancer and autoimmune disorders |
| JP2013544235A (ja) | 2010-10-15 | 2013-12-12 | メドイミューン・リミテッド | 肺機能を改善する治療法 |
| KR101615474B1 (ko) | 2010-12-16 | 2016-04-25 | 제넨테크, 인크. | Th2 억제에 관한 진단 및 치료 |
| US8961965B2 (en) | 2011-05-18 | 2015-02-24 | Medimmune, Llc | Methods of diagnosing and treating pulmonary diseases or disorders |
| KR20160113700A (ko) | 2014-01-27 | 2016-09-30 | 메디뮨 엘엘씨 | 천식 폐에서의 il-13 활성화의 말초 바이오마커로서의 디펩티딜 펩티다제-4(dpp4/cd26) |
-
2016
- 2016-01-08 KR KR1020177021858A patent/KR20170098941A/ko not_active Withdrawn
- 2016-01-08 AU AU2016205188A patent/AU2016205188A1/en not_active Abandoned
- 2016-01-08 SG SG11201705598VA patent/SG11201705598VA/en unknown
- 2016-01-08 MX MX2017008748A patent/MX2017008748A/es unknown
- 2016-01-08 HK HK18103568.6A patent/HK1243953A1/zh unknown
- 2016-01-08 CN CN201680005264.3A patent/CN107206079A/zh active Pending
- 2016-01-08 RU RU2017127182A patent/RU2017127182A/ru not_active Application Discontinuation
- 2016-01-08 WO PCT/US2016/012603 patent/WO2016112261A2/en not_active Ceased
- 2016-01-08 HK HK18103970.8A patent/HK1244444A1/zh unknown
- 2016-01-08 CA CA2970540A patent/CA2970540A1/en not_active Abandoned
- 2016-01-08 EP EP16735457.0A patent/EP3242686B1/en active Active
- 2016-01-08 US US14/991,160 patent/US10351630B2/en active Active
- 2016-01-08 JP JP2017536325A patent/JP2018502577A/ja active Pending
- 2016-01-08 BR BR112017011724-0A patent/BR112017011724A2/pt not_active Application Discontinuation
-
2017
- 2017-05-25 IL IL252528A patent/IL252528A0/en unknown
-
2019
- 2019-06-06 US US16/433,174 patent/US20190352425A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2970540A1 (en) | 2016-07-14 |
| JP2018502577A (ja) | 2018-02-01 |
| AU2016205188A1 (en) | 2017-06-22 |
| US20160200832A1 (en) | 2016-07-14 |
| EP3242686A2 (en) | 2017-11-15 |
| WO2016112261A3 (en) | 2016-09-01 |
| HK1244444A1 (zh) | 2018-08-10 |
| IL252528A0 (en) | 2017-07-31 |
| US10351630B2 (en) | 2019-07-16 |
| HK1243953A1 (zh) | 2018-07-27 |
| CN107206079A (zh) | 2017-09-26 |
| KR20170098941A (ko) | 2017-08-30 |
| MX2017008748A (es) | 2017-11-17 |
| WO2016112261A2 (en) | 2016-07-14 |
| EP3242686B1 (en) | 2020-07-08 |
| EP3242686A4 (en) | 2018-06-06 |
| SG11201705598VA (en) | 2017-08-30 |
| BR112017011724A2 (pt) | 2018-05-15 |
| US20190352425A1 (en) | 2019-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112250763B (zh) | 靶向SARS-CoV-2冠状病毒的抗体及其诊断和检测用途 | |
| JP7399096B2 (ja) | 神経変性を検出するためのアッセイ | |
| CN102112489B (zh) | 抗-hepcidin-25选择性抗体及其用途 | |
| CN113214393B (zh) | Il-6抗体或其抗原结合片段及包含其的检测试剂盒 | |
| JP2017507322A5 (enExample) | ||
| CN113891746A (zh) | 焦谷氨酸淀粉样蛋白-β的抗体及其用途 | |
| JP2017524362A5 (enExample) | ||
| US11142572B2 (en) | Antibodies to human erythroferrone and uses thereof | |
| RU2017127182A (ru) | Анализ для детекции dpp-4 человека | |
| CN114594272B (zh) | 用于检测β-淀粉样蛋白的产品和方法 | |
| JP2012153664A (ja) | 抗ｉｌ２８ｂ抗体及びこれを用いたｉｌ２８ｂの測定方法 | |
| JP7434144B2 (ja) | ＡＰＰ６６９－ｘのＮ末端を特異的に認識する抗体、及び免疫測定法 | |
| CN104830804B (zh) | 一种翻译控制肿瘤蛋白的单克隆抗体杂交瘤及其单克隆抗体与应用 | |
| CN104830805B (zh) | 抗人翻译控制肿瘤蛋白单克隆抗体杂交瘤及其单克隆抗体与应用 | |
| WO2022238481A1 (en) | Antibodies | |
| JP2018502577A5 (enExample) | ||
| JP2019501152A (ja) | Ｃｇｒｐ抗体及びその使用 | |
| CN119264254B (zh) | 抗降钙素原抗体及包括该抗体的检测试剂盒 | |
| CN116143929B (zh) | 抗重组人凝血因子VIIa-Fc融合蛋白的抗体及其应用 | |
| CN114853887B (zh) | 一种特异性结合α-突触核蛋白的抗体及其应用 | |
| US20230125690A1 (en) | Antibody for detecting acetylation of cox2 protein, and uses thereof | |
| JP2025186346A (ja) | 神経変性を検出するためのアッセイ | |
| WO2025242736A1 (en) | Antibodies specific to human hmgi-c antigen and use thereof | |
| WO2024213001A1 (zh) | 抗nmi单克隆抗体或其抗原结合片段及其应用 | |
| WO2025224316A1 (en) | Antibodies specific to human hmgi-c antigen and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20200729 |